D-allulose attenuates dyslipidemia, oxidative stress, and inflammation in high-fat-diet-induced metabolic dysfunction-associated steatotic liver disease in rats
D-allulose shows promising protective impacts as a bioactive ingredient for obesity-related metabolic disorders and attenuated HFD-induced hepatic steatosis, degeneration, necrosis, inflammation, and early fibrosis, while improving antioxidant status.